Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2005-06 | Page 63

# NOTES TO THE ACCOUNTS

**Reporting Period:** For the year ended 2006  
**Reporting Currency & Multiplier:** Tk. | **Scale Multiplier:** 1.0

### 45. Other Income - Tk. 56,201,142

| Particulars | 2006 | 2005 |
| --- | --- | --- |
| Interest Income | 43,748,781 | 2,873,370 |
| Cash Dividend received | 1,900,336 | 1,520,269 |
| Exchange gain on retention quota (F.C.) accounts | 54,441 | 1,169,216 |
| Gain on Sale of shares in Bextex Ltd. | 10,121,382 | - |
| Liability against customs Debenture Written off | - | 1,758,387 |
| (Loss)/profit on sale of Fixed Assets | 376,202 | (88,633) |
| [Total Other Income] | 56,201,142 | 7,232,609 |

### 46. Finance Cost - Tk. 253,318,784

| Particulars | 2006 | 2005 |
| --- | --- | --- |
| Interest on Cash Credit and others | 229,719,450 | 202,541,434 |
| Interest on loan from PF and WPP & Welfare Fund | 23,599,334 | 19,407,890 |
| [Total Finance Cost] | 253,318,784 | 221,949,324 |

### 48. Income Tax (Income)/Expenses - Tk. 52,585,106

| Notes | Particulars | 2006 | 2005 |
| --- | --- | --- | --- |
|  | (i) Current Tax | 35,402,549 | 46,169,026 |
| 19.5 & 33 | (ii) Deferred Tax (Income)/Expense | 17,182,557 | (50,064,120) |
|  | [Total Income Tax (Income)/Expenses] | 52,585,106 | (3,895,094) |
|  | Tax for the year under review | 43,413,478 | 43,217,283 |
|  | Short/(Excess) provision of Tax relating to earlier years | (8,010,929) | 2,951,743 |
|  | [Total Current Tax consists of] | 35,402,549 | 46,169,026 |

### 49. Earnings Per Share (EPS) :

| Particulars | 2006 | 2005 |
| --- | --- | --- |
| (a) Earnings attributable to the Ordinary Shareholders (Net profit after Tax) | 470,658,563 | 489,261,764 |
| (b) Weighted average number of Ordinary Shares outstanding during the year | 100,737,415 | 76,878,446 |
| Earnings Per Share (EPS) | 4.67 | 6.36 |